ArticleCureus2026
A Case of Non-diabetic Hypoglycemia in the Elderly: Insulin Autoimmune Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insulin autoimmune syndrome (IAS), also known as Hirata syndrome, is a rare cause of spontaneous hyperinsulinemic hypoglycemia, most commonly reported in Asian populations, characterized by the presence of insulin autoantibodies in individuals without prior exposure to exogenous insulin. We report the case of a 71-year-old woman who presented with recurrent postprandial hypoglycemic episodes associated with neuroglycopenic symptoms. There was no history of insulin use, oral hypoglycemic agents, or exposure to drugs known to precipitate IAS. Biochemical evaluation demonstrated marked hyperinsulinemia (>1000 µIU/mL), elevated C-peptide levels, an insulin-to-C-peptide ratio >1, and positive insulin autoantibodies, confirming the diagnosis. Anti-thyroid peroxidase antibodies were elevated with normal thyroid function, suggesting an underlying autoimmune predisposition. She was treated with corticosteroids and dietary modification, resulting in complete resolution without recurrence. Steroids were tapered and discontinued over three months with sustained remission. IAS should be considered in cases of non-diabetic hypoglycemia, and early diagnosis with appropriate management can prevent complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.